You are using an outdated browser. Please upgrade your browser to improve your experience.

risankizumab

Ligand Summary
Description
Skyrizi is a medicine used to treat plaque psoriasis, a disease causing red, scaly patches on the skin. Indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy
Synonyms & Links
DrugCentral: 5337
LyCHI:  risankizumab


loading...
Target Activities